Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 5, 2014, Pages 2382-2391

  Cui, Xiaobin ^a,b   Li, Su ^a   Li, Tingting ^a   Pang, Xuelian ^a   Zhang, Shumao ^a   Jin, Jing ^a   Hu, Jianming ^a   Liu, Chunxia ^a   Yang, Lan ^a   Peng, Hao ^a   Jiang, Jinfang ^a   Liang, Weihua ^a   Suo, Jing ^a   Li, Feng ^a,b   Chen, Yunzhao ^a  

^a SHIHEZI UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epidermal growth factor receptor; Esophageal squamous cell carcinoma; Extracellular signal regulated kinase; Kazakh

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; MAPK1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TUMOR MARKER;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CANCER GRADING; CANCER STAGING; CELL NUCLEUS; CHINA; CYTOPLASM; ENZYMOLOGY; EPIDEMIOLOGY; ESOPHAGUS TUMOR; ETHNOLOGY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; SECONDARY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; UPREGULATION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CHINA; CYTOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM GRADING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84902463790     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Parkin DM, Bray F, Ferlay J and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Huang L, Lu Q, Han Y, Li Z, Zhang Z, Li X. ABCG2/V-ATPase was associated with the drug resistance and tumor metastasis of esophageal squamous cancer cells. Diagn Pathol 2012; 7: 1746-1596.
3. Wang GQ, Abnet CC, Shen Q, Lewin KJ, Sun XD, Roth MJ, Qiao YL, Mark SD, Dong ZW, Taylor PR and Dawsey SM. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 2005; 54: 187-192.
4. Cui X, Zhao Z, Liu D, Guo T, Li S, Hu J, Liu C, Yang L, Cao Y, Jiang J, Liang W, Liu W, Li S, Wang L, Wang L, Gu W, Wu C, Chen Y, Li F. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma. J Exp Clin Cancer Res 2014; 33: 20.
5. Cui X, Chen Y, Liu L, Li L, Hu J, Yang L, Liang W, Li F. Heterozygote of PLCE1 rs2274223 increases susceptibility to human papillomavirus infection in patients with esophageal carcinoma among the Kazakh populations. J Med Virol 2014; 86: 608-617.
6. Rice TW, Rusch VW, Apperson-Hansen C, Allen MS, Chen LQ, Hunter JG, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Swisher SG, Watson TJ and Blackstone EH. Worldwide esophageal cancer collaboration. Dis Esophagus 2009; 22: 1-8.
7. Yarden Y and Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 1987; 26: 1443-1451.
8. Holbro T, Civenni G and Hynes NE. The ErbB receptors and their role in cancer progression. Exp Cell Res 2003; 284: 99-110.
9. Pawson T and Nash P. Protein-protein interactions define specificity in signal transduction. Genes Dev 2000; 14: 1027-1047.
10. Elisa G, Fabio A, Turano C and Silvia C. The protein ERp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells. J Cell Biochem 2013; 114: 2461-70.
11. Najar AG, Pashaei-Asl R, Omidi Y, Farajnia S and Nourazarian AR. EGFR antisense oligonucleotides encapsulated with nanoparticles decrease EGFR, MAPK1 and STAT5 expression in a human colon cancer cell line. Asian Pac J Cancer Prev 2013; 14: 495-498.
12. Hong L, Han Y, Zhang H, Zhao Q, Yang J and Ahuja N. High expression of epidermal growth factor receptor might predict poor survival in patients with colon cancer: a meta-analysis. Genet Test Mol Biomarkers 2013; 17: 348-351.
13. Zhang YW, Staal B, Essenburg C, Lewis S, Kaufman D and Vande Woude GF. Strengthening Context-Dependent Anti-Cancer Effects on Non-Small Cell Lung Carcinoma by Inhibition of Both MET and EGFR. Mol Cancer Ther 2013; 12: 1429-41.
14. Zhang M, Mu XY, Jiang SJ, Liu QL and Li DW. Relationship between epidermal growth factor receptor gene expression and radiosensitivity of non-small-cell lung cancer cells. Zhonghua Zhong Liu Za Zhi 2013; 35: 94-97.
15. Abedi-Ardekani B, Dar NA, Mir MM, Zargar SA, Lone MM, Martel-Planche G, Villar S, Mounawar M, Saidi F, Malekzadeh R and Hainaut P. Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia. BMC Cancer 2012; 12: 602.
16. Yang YL, Xu KL, Zhou Y, Gao X and Chen LR. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas. Chin Med J (Engl) 2012; 125: 450-454.
17. Okines A, Cunningham D and Chau I. Targeting the human EGFR family in esophagogastric cancer. Nat Rev Clin Oncol 2011; 8: 492-503.
18. Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y and Kelly K. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation. BMC Cancer 2008; 8: 189.
19. Peng H, Dara L, Li TW, Zheng Y, Yang H, Tomasi ML, Tomasi I, Giordano P, Mato JM and Lu SC. MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology 2013; 57: 2299-2313.
20. Dong QZ, Wang Y, Tang ZP, Fu L, Li QC, Wang ED and Wang EH. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol 2013; 182: 954-964.
21. Zhang J, Zhi H, Zhou C, Ding F, Luo A, Zhang X, Sun Y, Wang X, Wu M and Liu Z. Up-regulation of fibronectin in oesophageal squamous cell carcinoma is associated with activation of the Erk pathway. J Pathol 2005; 207: 402-409.
22. Zheng ST, Liu T, Middottuersun A, Huo Q, Liu Q, Huang CG, Feng JG, Lu GD, Wang X, Lin RY, Sheyhidin I and Lu XM. Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients. Zhonghua Zhong Liu Za Zhi 2011; 33: 421-425.
23. Pengnan Z, Zhang P, Min Z, Hua J, Haiyan Z, Bizhi S, Xiaorong P, Huiping G, Hong S and Zonghai L. Exon 4-Deletion Variant of Epidermal Growth Factor Receptor Enhances Invasiveness and Cisplatin Resistance in Epithelial Ovarian Cancer. Carcinogenesis 2013; 34: 2639-46.
24. Zhang X, Diaz MR and Yee D. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells. Breast Cancer Res Treat 2013; 139: 351-360.
25. Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, Liu Z, Zhan Q, Liu Y, Yu D, Zhai K, Chang J, Qiao Y, Jin G, Shen Y, Guo C, Fu J, Miao X, Tan W, Shen H, Ke Y, Zeng Y, Wu T and Lin D. Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet 2011; 43: 679-684.
26. Wang LD, Zhou FY, Li XM, Sun LD, Song X, Jin Y, Li JM, Kong GQ, Qi H, Cui J, Zhang LQ, Yang JZ, Li JL, Li XC, Ren JL, Liu ZC, Gao WJ, Yuan L, Wei W, Zhang YR, Wang WP, Sheyhidin I, Li F, Chen BP, Ren SW, Liu B, Li D, Ku JW, Fan ZM, Zhou SL, Guo ZG, Zhao XK, Liu N, Ai YH, Shen FF, Cui WY, Song S, Guo T, Huang J, Yuan C, Wu Y, Yue WB, Feng CW, Li HL, Wang Y, Tian JY, Lu Y, Yuan Y, Zhu WL, Liu M, Fu WJ, Yang X, Wang HJ, Han SL, Chen J, Han M, Wang HY, Zhang P, Dong JC, Xing GL, Wang R, Guo M, Chang ZW, Liu HL, Guo L, Yuan ZQ, Liu H, Lu Q, Yang LQ, Zhu FG, Yang XF, Feng XS, Wang Z, Li Y, Gao SG, Qige Q, Bai LT, Yang WJ, Lei GY, Shen ZY, Chen LQ, Li EM, Xu LY, Wu ZY, Cao WK, Wang JP, Bao ZQ, Chen JL, Ding GC, Zhuang X, Zhou YF, Zheng HF, Zhang Z, Zuo XB, Dong ZM, Fan DM, He X, Wang J, Zhou Q, Zhang QX, Jiao XY, Lian SY, Ji AF, Lu XM, Wang JS, Chang FB, Lu CD, Chen ZG, Miao JJ, Fan ZL, Lin RB, Liu TJ, Wei JC, Kong QP, Lan Y, Fan YJ, Gao FS, Wang TY, Xie D, Chen SQ, Yang WC, Hong JY, Wang L, Qiu SL, Cai ZM and Zhang XJ. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010; 42: 759-763.
27. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Dong LM, Lee MP, Ding T, Qiao YL, Gao YT, Koh WP, Xiang YB, Tang ZZ, Fan JH, Wang C, Wheeler W, Gail MH, Yeager M, Yuenger J, Hutchinson A, Jacobs KB, Giffen CA, Burdett L, Fraumeni JF Jr, Tucker MA, Chow WH, Goldstein AM, Chanock SJ and Taylor PR. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet 2010; 42: 764-767.
28. Chen YZ, Cui XB, Hu JM, Zhang WJ, Li SG, Yang L, Shen XH, Liu CX, Pan QF, Yu SY, Yuan XL, Gu WY, Chen JZ, Wang LD and Li F. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness. APMIS 2013; 121: 908-18.
29. Cui XB, Chen YZ, Pang XL, Liu W, Hu JM, Li SG, Yang L, Zhang WJ, Liu CX, Cao YW, Jiang JF, Gu WY, Pang J, Yang L, Yuan XL, Yu SY, Li F. Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population. Gene 2013; 530: 315-322.
30. Cui XB, Pang XL, Li S, Jin J, Hu JM, Yang L, Liu CX, Li L, Wen SJ, Liang WH, Chen YZ, Li F. Elevated expression patterns and tight correlation of the PLCE1 and NF-kappaB signaling in Kazakh patients with esophageal carcinoma. Med Oncol 2014; 31: 791.
31. Balmanno K and Cook SJ. Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 2009; 16: 368-377.
32. Lee HJ, Kim DI, Kang GH, Kwak C, Ku JH and Moon KC. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma. Urology 2009; 73: 394-399.
33. Huynh H, Nguyen TT, Chow KH, Tan PH, Soo KC and Tran E. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol 2003; 3: 19.
34. Bang YJ, Kwon JH, Kang SH, Kim JW and Yang YC. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. Biochem Biophys Res Commun 1998; 250: 43-47.
35. Garavello W, Nicolini G, Aguzzi A, Maggioni D, Leone BE, Vigano P, Gaini RM and Tredici G. Selective reduction of extracellular signal-regulated protein kinase (ERK). Oncol Rep 2006; 16: 479-484.
36. Tang DG, Rybak AP, Ingram AJ and Tang D. Propagation of Human Prostate Cancer Stem-Like Cells Occurs through EGFR-Mediated ERK Activation. PLoS One 2013; 8: e61716.
37. Itakura Y, Sasano H, Shiga C, Furukawa Y, Shiga K, Mori S and Nagura H. Epidermal growth factor receptor overexpression in esophageal carcinoma. An immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994; 74: 795-804.
38. Tong M, Chan KW, Bao JY, Wong KY, Chen JN, Kwan PS, Tang KH, Fu L, Qin YR, Lok S, Guan XY and Ma S. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res 2012; 72: 6024-6035.
39. Wong VC, Chen H, Ko JM, Chan KW, Chan YP, Law S, Chua D, Kwong DL, Lung HL, Srivastava G, Tang JC, Tsao SW, Zabarovsky ER, Stanbridge EJ and Lung ML. Tumor suppressor dual- specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer 2012; 130: 83-95.
40. Shin WS, Kwon J, Lee HW, Kang MC, Na HW, Lee ST and Park JH. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. Cancer Sci 2013; 104: 1120-6.
41. Cao W, Zhang B, Ding F, Zhang W, Sun B and Liu Z. Expression of SLP-2 Was Associated with Invasion of Esophageal Squamous Cell Carcinoma. PLoS One 2013; 8: e63890.
42. Zhu G, Zhou J, Song W, Wu D, Dang Q, Zhang L, Li L, Wang X and He D. Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells. Oncol Rep 2013; 30: 904-10.
43. Ge MH, Ling ZQ, Tan Z, Chen C, Xu JJ and Yu JL. Expression of epidermal growth factor receptor in salivary adenoid cystic carcinoma and its role in cancer invasion. Zhonghua Zhong Liu Za Zhi 2012; 34: 278-280.
44. Breindel JL, Haskins JW, Cowell EP, Zhao M, Nguyen DX and Stern DF. EGF Receptor activates MET through MAP kinases to enhance non-small cell lung carcinoma invasion and brain metastasis. Cancer Res 2013; 73: 5053-65.
45. Wang YP, Huang LY, Sun WM, Zhang ZZ, Fang JZ, Wei BF, Wu BH and Han ZG. Insulin receptor tyrosine kinase substrate activates EGFR/ERK signalling pathway and promotes cell proliferation of hepatocellular carcinoma. Cancer Lett 2013; 337: 96-106.
46. Chen HJ, Jiang YL, Lin CM, Tsai SC, Peng SF, Fushiya S, Hour MJ and Yang JS. Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells. Int J Oncol 2013; 43: 141-150.